At the European CAR T-cell meeting, we spoke with Johanna Richter to hear about the preliminary data from a single-center experience with CD19-directed CAR-T in patients with #MultipleSclerosis.
Watch here:
👉 buff.ly/Xyuvgwu
#MS #MultScler #CART25 #Neurology
🩸To hear the results of a Phase II study of parsaclisib for the treatment of primary autoimmune hemolytic #anemia, watch our recent interview with Prof. Ulrich Jäger below:
🎥 buff.ly/XXAXe4j
#CART25 #Hematology #CTSM #TrialUpdate #MedSky #BloodSky
Are in vivo genome editing methods for targeting T-cells the future of CAR-T?🧬
What are some of their benefits, and what challenges remain?
Hear from Dr William Nyberg in a recent interview from #CART25:
🎥 buff.ly/E146kjE
#ImmunoOnc #HemOnc #CARTCell #BloodSky
In an interview from #CART25, Prof. Christian Buchholz shares insight into advancements in #CARTCell manufacturing, mentioning two novel strategies being developed – short-term CAR T-cells & in vivo CAR delivery.
Watch here:
👉 buff.ly/49Y0DOh
#ImmunoOnc #HemOnc
At #CART25 we had the pleasure of speaking with the lovely @orlamccourt.bsky.social of @uclh.bsky.social to gain insight into a single-center experience of implementing physiotherapist-led prehabilitation for #CARTCell therapy.
Click here to learn more:
👉 buff.ly/8UM5VqR
#ImmunoOnc #HemOnc
Could mitochondrial transfer be harnessed to improve the efficacy of T-cell therapy?
Luca Gattinoni is studying this, and we had the pleasure of hearing about his work at the recent European CAR-T Meeting!
Watch here:
👉 buff.ly/bFko3tk 👈
#ImmunoOnc #HemOnc #CART25
At #CART25, the lovely Natacha Bolaños shared an analysis of the Lymphoma Coalition’s Global Patient Survey investigating patient-reported side effects for #CARTCell therapy vs other therapies in relapsed lymphomas & CLL.
Click to watch:
🎥 buff.ly/zDEwxYQ
#LYMsm #Leusm #CLLsm #HemOnc
At #CART25, Maik Luu spoke on the potential of microbiome-derived metabolites to guide patient outcome prediction & #CARTCell engineering, highlighting the discovery of the microbial postbiotic pentanoate:
🎥 buff.ly/F32c2Ra
#ImmunoOnc #HemOnc
🎥 In an interesting interview at #CART25, Andrea Kuhnl provided insight into CAR-T outcomes in patients with LBCL in the UK according to ethnicity and socioeconomic deprivation.
Watch here:
👉 buff.ly/3KHC04h 👈
#LYMsm #DLBCL #ImmunoOnc #HemOnc
Did you miss this year's EHA-EBMT European CAR T-cell meeting?🩸💉
Not to worry! We were there to capture key updates.🎥
You can check out our exclusive expert interviews from the event here:
👉 buff.ly/RID6wue 👈
#ImmunoOnc #CARTCell #CART25
#CART25 | Christian Chabannon shares updates on ongoing projects of the #GoCARTcoalition!
Click here to watch the interview:
👉 buff.ly/4hSG1Po 👈
#ImmunoOnc #HemOnc #CARTCell #Hematology #MedSky #BloodSky #HemeSky
The incidence of cardiac complications after CAR T-cell therapy may be higher than initially thought.🫀💉
Watch our interview with Roni Shouval of @mskcancercenter.bsky.social from #CART25 to find out more:
👉 buff.ly/415vNnB 👈
#ImmunoOnc #HemOnc #CARTCell #Hematology #MedSky #BloodSky #HemeSky
Hear about the status of #CARTCell therapy in acute and chronic leukemias (ALL, AML, CLL) in our interview from #CART25 with Ulrich Jäger:
👉 https://buff.ly/3QhuKfw 👈
#Leusm #Leukemia #ALLsm #AMLsm #CLLsm #ImmunoOnc #HemOnc
Thank you to Valentín Ortiz-Maldonado for stopping by at #CART25 to share the results of the pivotal CART19-BE-02 trial investigating var-cel in adult R/R B-ALL!
Watch here:
👉 https://buff.ly/3EDdDCs
#ALLsm #Leusm #CARTCell #CTSM #TrialUpdate #ImmunoOnc #MedSky #BloodSky #HemeSky #HemeOnc
🎥 Check out our recent interview from #CART25 with @nicogagelmann.bsky.social, in which he highlights the need to address inequality & inequity in access to #CARTCell therapy across Europe:
👉 buff.ly/4gBhWeD
#ImmunoOnc #HemOnc #Hematology #MedSky #BloodSky #HemeSky
At #CART25, we had the pleasure of speaking with Elise Pennings & Anne Spanjaart, who shared insight into their work on patient-reported outcomes of #CARTCell therapy.
Don't miss this fantastic interview:
👉 https://buff.ly/41dvdpp 👈
#HemOnc #Hematology #MedSky #BloodSky #HemeSky #LYMsm
#CART25 | Tanya Siddiqi of @cityofhope.bsky.social shares updates on the recent approval of CAR-T for patients with CLL, commenting on where #CARTCell therapy may fit into the treatment landscape and referencing the TRANSCEND-CLL-004 trial:
🎥 https://buff.ly/3CR8E0f
#CLLsm #Leusm #CTSM #HemOnc
At #CART25 last week, Pere Barba of @vhio.bsky.social shared updated results from the FELIX trial, evaluating obe-cel in patients with R/R ALL.
Watch the interview here:
👉 https://buff.ly/40SDhKF 👈
#ALLsm #Leusm #CTSM #TrialUpdate #ImmunoOnc #MedSky #BloodSky #HemeSky #HemeOnc
We had a fantastic time at the 7th European CAR T-cell meeting!💉🩸
Thank you to the EBMT & EHA for having us onsite as a media partner again this year!😁
Check out some of our exclusive coverage of the event here:
👉 https://buff.ly/3QeT6qd 👈
#CART25 #CARTCell #Hematology #MedSky #BloodSky #HemeSky
Judith presented our recent #CARTcell research at the 7th European CAR T cell Meeting #CART25 in Strasbourg.🧬🧫
Many thanks to the organizers @EHA_Hematology and @EBMT for this inspiring event.
#TeamJJ
MAKE CAR-T AFFORDABLE AGAIN
Terrific learning experience from cellular therapy programs in India, Slovenia, Brazil and Turkey
#CART25
It's the final day of the EHA-EBMT European CAR-T Meeting, and we have more exciting interviews with leading experts lined up!🎥
We will be sharing our content from the meeting soon, so keep an eye out on VJHemOnc.com! 👀
#CARTCell #CART25 #ImmunoOnc #HemOnc
Really fantastic session on the importance of shared decision making rounding off a brilliant nursing and AHP programme at EHA EBMT #CART25
🩸 #CARTCell therapy in acute & #chronicleukemias
🩸the role of the microenvironment in CAR-T
🩸treating #autoimmune hemolytic #anemia
These are all topics we discussed today at #CART25 with Prof. Ulrich Jäger 🎥
Stay tuned for the interview VJHemOnc.com ! 👀
#Leusm #ImmunoOnc #HemOnc
🎥The wonderful Natacha Bolaños of Lymphoma Coalition gave a summary of a patient in focus session on #CARTCell therapy accessibility challenges & also discussed patient-reported side-effects for CAR-T vs other therapies in relapsed #lymphoma & CLL🩸🎥
#CLLsm #Leusm #ImmunoOnc #CART25
It's always a pleasure to speak with Tanya Siddiqi of
@cityofhope.bsky.social! 🧡
Today at #CART25, Dr Siddiqi provided valuable insight into CAR-T in #CLL, including an update on the TRANSCEND CLL 004 trial & future directions 🔦🩸
Stay tuned for the full interview!🎥
#Leusm #HemOnc #CARTCell
#CART25 | We caught up with Pere Barba who discussed all things CAR-T in ALL and gave an update on the FELIX trial 🩸 🎥
We can't wait to share this fantastic interview on vjhemonc.com! 🔜
#ALLsm #Leusm #ImmunoOnc #CARTCel
Thank you to Roni Shouval @mskcancercenter.bsky.social for stopping by to discuss cardiac complications after CAR-T & to provide insight into treatment failure patterns in early vs late introduction of CAR-T in LBCL 🩸
Look out for the interview soon! 👀 🎥 #CART25 #Lymphoma #LYMsm #ImmunoOnc
We are so excited to be onsite at the EHA-EBMT European CAR-T Meeting today!🇫🇷
Not only that, we are thrilled to be media partners for the event!😁
Make sure to follow us to keep up with our exclusive coverage.🎥
#ImmunoOnc #HemOnc #CARTCell #CART25
